- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
New Collaboration to Promote Discovery of Innovative Respiratory Therapies
Weill Cornell Medicine and Boehringer Ingelheim have announced a collaboration that will investigate novel approaches to treating chronic respiratory disease.
Weill Cornell Medicine and Boehringer Ingelheim have announced a collaboration that will investigate novel approaches to treating chronic respiratory disease.
The 3-year collaboration will unite Weill Cornell’s Department of Genetic Medicine with pharmaceutical company Boehringer Ingelheim so both parties can bring their unique experience to the table. The geneticists will utilize the resources and expertise of the cutting-edge drug developer to transform their research into effective treatments. They have already worked together on a similar project involving inflammatory bowel disease.
Most treatments for chronic lower respiratory diseases, which include chronic obstructive pulmonary disorder (COPD), involve treating symptoms and preserving quality of life for the more than 15 million Americans living with COPD. However, the newly announced partnership is aiming higher, seeking innovative therapies that can halt or even reverse the progression of COPD.
“Our continuous search for molecular drivers of chronic obstructive airway diseases has revealed novel repair mechanisms that warrant further investigation of their potential as therapeutic approaches,” Ronald G. Crystal, MD, Chairman of Genetic Medicine, said in a press statement announcing the joint project. “We will look to further expand our knowledge about progressive airway destruction in close collaboration with Boehringer Ingelheim and focus on promising therapeutic concepts with the potential to slow down or halt progressive airway damage in patients with COPD.”
Clive R. Wood, PhD, senior corporate vice president of Discovery Research at Boehringer Ingelheim, praised Crystal’s work in the announcement, calling him “one of the leading scientists in severe progressive airway diseases worldwide.” He voiced optimism about the collaboration’s success and predicted it would “translate new discoveries into drug discovery.”
“The new collaboration is an excellent example of our unique partnering approach and our focus on early innovation, underscoring our ambition to develop the next generation of medical treatments for patients with COPD,” he concluded.
Health Care Utilization and Cost of Diagnostic Testing for Respiratory Infections
September 17th 2025Syndromic reverse transcriptase–polymerase chain reaction tests for respiratory infections were associated with lower health care resource utilization and costs, implicating potential for improved value in patient care.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Rurality, Long Travel Times Limit Access to Tobacco Treatment for Patients With COPD Who Smoke
August 30th 2025Patients with chronic obstructive pulmonary disease (COPD) who smoke were less likely to receive tobacco dependence treatment (TDT) if they lived in rural areas or had longer travel times to care, highlighting persistent geographic disparities in access.
Read More
Preventing Respiratory Illness and Death Through Tighter Air Quality Standards
June 1st 2021On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.
Listen
Multidisciplinary Approaches to Pediatric Obstructive Sleep Apnea: A Review of Respiratory Therapies
August 13th 2025The treatment of pediatric obstructive sleep apnea syndrome is moving toward a personalized, multidisciplinary approach that combines surgical options with a growing number of nonsurgical alternatives, to better address the unique needs of each child.
Read More
